NCT05417386 2025-11-18FOLFIRINOX + NIS793 in Pancreatic CancerMassachusetts General HospitalPhase 1 Terminated4 enrolled
NCT03373188 2024-03-20VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal CancerEmory UniversityPhase 1 Completed10 enrolled